865
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Comparison study of the effect of alkyl-modified and unmodified PAMAM and PPI dendrimers on solubility and antitumor activity of crocetin

, , , &
Pages 1356-1362 | Received 05 Jul 2016, Accepted 11 Sep 2016, Published online: 31 Oct 2016

References

  • Ahmad AS, Ansari MA, Ahmad M, Saleem S, Yousuf S, Hoda MN, Islam F. 2005. Neuroprotection by crocetin in a hemi-Parkinsonian rat model. Pharmacol Biochem Behav. 81:805–813.
  • Ayatollahi S, Hashemi M, Kazemi Oskuee R, Salmasi Z, Mokhtarzadeh A, Alibolandi M, Abnous K, Ramezani M. 2015. Synthesis of efficient gene delivery systems by grafting PEGylated alkylcarboxylate chains to PAMAM dendrimers: evaluation of transfection efficiency and cytotoxicity in cancerous and mesenchymal stem cells. J Biomater Appl. 30:632–648.
  • Baars MW, Kleppinger R, Koch MH, Yeu SL, Meijer EW. 2000. The localization of guests in water-soluble oligoethyleneoxy-modified poly(propylene imine) dendrimers. Angew Chem Int Ed Engl. 39:1285–1288.
  • Bathaie SZ, Farajzade A, Hoshyar R. 2014. A review of the chemistry and uses of crocins and crocetin, the carotenoid natural dyes in saffron, with particular emphasis on applications as colorants including their use as biological stains. Biotech Histochem. 89:401–411.
  • Beezer AE, King ASH, Martin IK, Mitchel JC, Twyman LJ, Wain CF. 2003. Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivatives. Tetrahedron. 59:3873–3880.
  • Cai Z, Wang Y, Zhu LJ, Liu ZQ. 2010. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs. Curr Drug Metab. 11:197–207.
  • Chauhan AS. 2015. Dendrimer nanotechnology for enhanced formulation and controlled delivery of resveratrol. Ann NY Acad Sci. 1348:134–140.
  • Chauhan AS, Jain NK, Diwan PV, Khopade AJ. 2004. Solubility enhancement of indomethacin with poly(amidoamine) dendrimers and targeting to inflammatory regions of arthritic rats. J Drug Target. 12:575–583.
  • Gu L, Wu Z, Qi X, He H, Ma X, Chou X, et al. 2013. Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin. Pharm Dev Technol. 18:1051–1057.
  • Gutheil WG, Reed G, Ray A, Anant S, Dhar A. 2012. Crocetin: an agent derived from saffron for prevention and therapy for cancer. Curr Pharm Biotechnol. 13:173–179.
  • Hafezi GZ, Alebooye LF, Mokhtarzadeh A, Ramezani M, Hashemi M. 2016. Evaluation of anti-cancer activity of PLGA nanoparticles containing crocetin. Artif Cells Nanomed Biotechnol. 21:1–6.
  • Hashemi M, Parhiz H, Mokhtarzadeh A, Tabatabai SM, Farzad SA, Shirvan HR, Ramezani M. 2015. Preparation of effective and safe gene carriers by grafting alkyl chains to generation 5 polypropyleneimine. AAPS PharmSciTech. 16:1002–1012.
  • Hashemi M, Sahraie Fard H, Amel Farzad S, Parhiz H, Ramezani M. 2013. Gene Transfer Enhancement By Alkylcarboxylation of Poly(Propylenimine). Nanomed J. 1:55–62.
  • Jain NK, Gupta U. 2008. Application of dendrimer–drug complexation in the enhancement of drug solubility and bioavailability. Expert Opin Drug Metab Toxicol. 4:1035–1052.
  • Jain S, Kesharwani P, Tekade RK, Jain NK. 2015. One platform comparison of solubilization potential of dendrimer with some solubilizing agents. Drug Dev Ind Pharm. 41:722–727.
  • Kanakis CD, Tarantilis PA, Tajmir-Riahi HA, Polissiou MG. 2007. Crocetin, dimethylcrocetin, and safranal bind human serum albumin: stability and antioxidative properties. J Agric Food Chem. 55:970–977.
  • Kim SH, Lee JM, Kim SC, Park CB, Lee PC. 2014. Proposed cytotoxic mechanisms of the saffron carotenoids crocin and crocetin on cancer cell lines. Biochem Cell Biol. 92:105–111.
  • Magesh V, DurgaBhavani K, Senthilnathan P, Rajendran P, Sakthisekaran D. 2009. In vivo protective effect of crocetin on benzo(a)pyrene-induced lung cancer in Swiss albino mice. Phytother Res. 23:533–539.
  • Majoros IJ, Myc A, Thomas T, Mehta CB, Baker JR. Jr. 2006. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Biomacromolecules. 7:572–579.
  • Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 65:55–63.
  • Mukerjee A, Vishwanatha JK. 2009. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res. 29:3867–3875.
  • Murugan E, Geetha Rani DP, Srinivasan K, Muthumary J. 2013. New surface hydroxylated and internally quaternised poly(propylene imine) dendrimers as efficient biocompatible drug carriers of norfloxacin. Expert Opin Drug Deliv. 10:1319–1334.
  • Nam KN, Park YM, Jung HJ, Lee JY, Min BD, Park SU, et al. 2010. Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells. Eur J Pharmacol. 648:110–116.
  • Ohno Y, Nakanishi T, Umigai N, Tsuruma K, Shimazawa M, Hara H. 2012. Oral administration of crocetin prevents inner retinal damage induced by N-methyl-D-aspartate in mice. Eur J Pharmacol. 690:84–89.
  • Oskuee RK, Dehshahri A, Shier WT, Ramezani M. 2009. Alkylcarboxylate grafting to polyethylenimine: a simple approach to producing a DNA nanocarrier with low toxicity. J Gene Med. 11:921–932.
  • Sideratou Z, Tsiourvas D, Paleos CM. 2001. Solubilization and release properties of PEGylated diaminobutane poly(propylene imine) dendrimers. J Colloid Interface Sci. 242:272–276.
  • Takahashi T, Hirose J, Kojima C, Harada A, Kono K. 2007. Synthesis of poly(amidoamine) dendron-bearing lipids with poly(ethylene glycol) grafts and their use for stabilization of nonviral gene vectors. Bioconjug Chem. 18:1163–1169.
  • Tseng TH, Chu CY, Huang JM, Shiow SJ, Wang CJ. 1995. Crocetin protects against oxidative damage in rat primary hepatocytes. Cancer Lett. 97:61–67.
  • Umigai N, Tanaka J, Tsuruma K, Shimazawa M, Hara H. 2012. Crocetin, a carotenoid derivative, inhibits VEGF-induced angiogenesis via suppression of p38 phosphorylation. Curr Neurovasc Res. 9:102–109.
  • Wang CJ, Shiow SJ, Lin JK. 1991. Effects of crocetin on the hepatotoxicity and hepatic DNA binding of aflatoxin B1 in rats. Carcinogenesis. 12:459–462.
  • Wang L, Xu X, Zhang Y, Zhang Y, Zhu Y, Shi J, Sun Y, Huang Q. 2013. Encapsulation of curcumin within poly(amidoamine) dendrimers for delivery to cancer cells. J Mater Sci Mater Med. 24:2137–2144.
  • Zhang R, Qian Z-Y, Han X-Y, Chen Z, Yan J-L, Hamid A. 2009. Comparison of the effects of crocetin and crocin on myocardial injury in rats. Chin J Nat Med. 7:223–227.
  • Zhao C, Wang Y, Su Y, Zhang H, Ding L, Yan X, et al. 2011. Inclusion complexes of isoflavones with two commercially available dendrimers: solubility, stability, structures, release behaviors, cytotoxicity, and anti-oxidant activities. Int J Pharm. 421:301–309.
  • Zhao L, Ye Y, Li J, Wei YM. 2011. Preparation and the in-vivo evaluation of paclitaxel liposomes for lung targeting delivery in dogs. J Pharm Pharmacol. 63:80–86.
  • Zhao BX, Zhao Y, Huang Y, Luo LM, Song P, Wang X, et al. 2012. The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel. Biomaterials. 33:2508–2520.
  • Zhou Z, D'Emanuele A, Attwood D. 2013. Solubility enhancement of paclitaxel using a linear-dendritic block copolymer. Int J Pharm. 452:173–179.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.